CPB vs LAB · P/E 12, rev $10.25B vs rev $174.4M
Campbell’s Co (CPB) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Campbell’s Co (CPB) is a packaged foods company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported CPB revenue for 2025-08-03 was $10.25B. Net income was $602.0M. Revenue was up 6.4% from 2024-07-28 to 2025-08-03. CPB currently screens at market cap $6.46B and trailing P/E 11.8.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
CPB currently screens at market cap $6.46B and trailing P/E 11.8. LAB currently screens at market cap $317.1M.
Not investment advice. Open the CPB and LAB stock pages for the full models.
Not investment advice.